TETRAPHASE PHARMACEUTICALS INC Operating Lease Cost
TETRAPHASE PHARMACEUTICALS INC reported Operating Lease Cost of $343.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2020-05-07
- TETRAPHASE PHARMACEUTICALS INC operating lease, cost for the quarter ending 2020-03-31 was $343.00K, a 27.64% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC operating lease, cost for the quarter ending 2019-12-31 was $474.00K.
- TETRAPHASE PHARMACEUTICALS INC operating lease, cost for the quarter ending 2019-09-30 was $474.00K.
- TETRAPHASE PHARMACEUTICALS INC operating lease, cost for the quarter ending 2019-06-30 was $474.00K.
- TETRAPHASE PHARMACEUTICALS INC operating lease, cost for fiscal 2019 was $1.90M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2020-03-31 | $343.00K 10-Q · filed 2020-05-07 | $817.00K derived: sum of 2 quarters · filed 2020-05-07 | $1.29M derived: sum of 3 quarters · filed 2020-05-07 | $1.76M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | $474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $948.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.42M derived: sum of 3 quarters · filed 2020-03-12 | $1.90M 10-K · filed 2020-03-12 |
| 2019-09-30 | $474.00K 10-Q · filed 2019-11-12 | $948.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.42M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $474.00K 10-Q · filed 2019-08-08 | $949.00K 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $474.00K 10-Q · filed 2020-05-07 |